1. Home
  2. IPHA vs EP Comparison

IPHA vs EP Comparison

Compare IPHA & EP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPHA
  • EP
  • Stock Information
  • Founded
  • IPHA 1999
  • EP 1983
  • Country
  • IPHA France
  • EP United States
  • Employees
  • IPHA N/A
  • EP N/A
  • Industry
  • IPHA Biotechnology: Pharmaceutical Preparations
  • EP Oil & Gas Production
  • Sector
  • IPHA Health Care
  • EP Energy
  • Exchange
  • IPHA Nasdaq
  • EP Nasdaq
  • Market Cap
  • IPHA 191.0M
  • EP 170.7M
  • IPO Year
  • IPHA 2019
  • EP N/A
  • Fundamental
  • Price
  • IPHA $2.28
  • EP $5.00
  • Analyst Decision
  • IPHA Strong Buy
  • EP
  • Analyst Count
  • IPHA 1
  • EP 0
  • Target Price
  • IPHA $11.50
  • EP N/A
  • AVG Volume (30 Days)
  • IPHA 5.5K
  • EP 38.8K
  • Earning Date
  • IPHA 09-12-2024
  • EP 09-24-2024
  • Dividend Yield
  • IPHA N/A
  • EP N/A
  • EPS Growth
  • IPHA N/A
  • EP N/A
  • EPS
  • IPHA N/A
  • EP N/A
  • Revenue
  • IPHA $36,202,722.00
  • EP $42,871,387.00
  • Revenue This Year
  • IPHA N/A
  • EP N/A
  • Revenue Next Year
  • IPHA $105.84
  • EP N/A
  • P/E Ratio
  • IPHA N/A
  • EP N/A
  • Revenue Growth
  • IPHA 6.88
  • EP N/A
  • 52 Week Low
  • IPHA $1.81
  • EP $4.06
  • 52 Week High
  • IPHA $3.15
  • EP $10.99
  • Technical
  • Relative Strength Index (RSI)
  • IPHA 50.55
  • EP 39.23
  • Support Level
  • IPHA $2.27
  • EP $4.60
  • Resistance Level
  • IPHA $2.41
  • EP $5.14
  • Average True Range (ATR)
  • IPHA 0.11
  • EP 0.27
  • MACD
  • IPHA -0.00
  • EP -0.08
  • Stochastic Oscillator
  • IPHA 52.94
  • EP 3.60

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

About EP Empire Petroleum Corporation

Empire Petroleum Corp is a conventional oil and natural gas producer with a main focus in the US onshore. The company possesses long-life, mature, producing assets with slow decline profiles in the Permian Basin, Bakken region and central Gulf Coast region, in the states of New Mexico, North Dakota, Montana, Louisiana and Texas. It has production from operated and non-operated wells in Lea County in New Mexico, Bottineau, Renville, Burke, and McKenzie Counties in North Dakota, Richland County in Montana, St. Landry, Beauregard Parishes in Louisiana and Houston, Leon and Madison Counties in Texas.

Share on Social Networks: